F2G said on Thursday it has raised $100 million from investors including AMR Action Fund, backed by large drugmakers such as Johnson & Johnson and Pfizer, to help it develop treatments for infections ...
Like bacteria with antibiotics, many fungal pathogens are increasingly developing resistance to antifungal drugs, scientists have highlighted this alarming trend while emphasising the need to include ...
Researchers analyzed the incidence in Japan of COVID-19-associated pulmonary aspergillosis (CAPA), a severe invasive fungal infection of the lungs, and found some insights related to risk factors and ...